Katherine Stueland, CHIEF EXECUTIVE OFFICER at GeneDx Holdings Corp. (WGS), sold 34,358 shares at $76.35 ($2.6M) on 2026-03-16, disclosed to the SEC on 2026-03-17.
Seasonal sale ($2.6M) by CHIEF EXECUTIVE OFFICER — this insider has traded WGS in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $76.35 | 7,178 | $548K | 20.8% |
| 2 | $76.35 | 7,178 | $548K | 20.8% |
| 3 | $77.05 | 9,229 | $711K | 26.9% |
| 4 | $77.05 | 9,229 | $711K | 26.9% |
| 5 | $77.94 | 772 | $60K | 2.3% |
| 6 | $77.94 | 772 |
| $60K |
| 2.3% |
| Total | $76.80 avg | 34,358 | $2.6M | 100% |
| Filing → |
| WGS | SELL | 2026-06-18 | $638K | — | Filing → |
| WGS | SELL | 2026-06-11 | $196K | — | Filing → |
| WGS | SELL | 2026-05-01 | $142K | — | Filing → |